Salvador
Martín Algarra
Consultor Médico
Hospital Miguel Servet
Zaragoza, EspañaPublications in collaboration with researchers from Hospital Miguel Servet (9)
2024
-
Access to melanoma drugs in Spain: a cross-sectional survey
Clinical and Translational Oncology, Vol. 26, Núm. 10, pp. 2572-2583
-
Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis
Clinical and Translational Oncology
2023
-
SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry
Clinical and Translational Oncology, Vol. 25, Núm. 3, pp. 768-775
2019
-
Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma
Oncologist, Vol. 24, Núm. 10, pp. 1375-1383
2018
-
Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients
Therapeutic Advances in Medical Oncology, Vol. 10
2017
-
Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access Program
Clinical and Translational Oncology, Vol. 19, Núm. 6, pp. 761-768
-
Report from the II Melanoma Translational Meeting of the Spanish Melanoma Group (GEM)
Annals of Translational Medicine, Vol. 5, Núm. 19
2016
-
Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: A retrospective study of the Grupo Español Multidisciplinar de Melanoma - Prima study
Melanoma Research, Vol. 26, Núm. 3, pp. 278-283
2015
-
Frequency and characteristics of familial melanoma in Spain: The FAM-GEM-1 study
PLoS ONE, Vol. 10, Núm. 4